Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical
presentation is highly variable but hypertension and proteinuria are usually seen. These …

The burden of preeclampsia, a substantial contributor to perinatal morbidity and mortality, is
not born equally across the population. Although the prevalence of preeclampsia has been …

Objective Hypertensive disorders are among the main causes of maternal and perinatal
morbidity and mortality, and the findings regarding the occurrence of preeclampsia (PE) and …

Background Hypertensive disorders of pregnancy (HDP) are associated with increased risk
of cardiovascular disease (CVD) 20-30 years later; however, cardiovascular (CV) risk in the …

Successful pregnancy relies on maternal immunologic tolerance mechanisms limit
maladaptive immune responses against the semi-allogeneic fetus and placenta and support …

Introduction Preeclampsia is a multisystemic, pregnancy-specific disorder united by new-
onset hypertension but with considerable variation in clinical manifestation, onset, and …

Background Preeclampsia is a leading contributor to maternal and perinatal morbidity and
mortality. In mice experiments, manganese (Mn) and selenium (Se) are protective whereas …

Background Black women have a disproportionately higher burden of both preeclamptic
pregnancy and stroke compared with White women, but virtually all existing evidence on this …

Hypertensive pregnancy is associated with increased maternal cardiovascular risk in later
life. A range of cardiovascular adaptations after pregnancy have been reported to partly …

Background Several human randomised controlled trials (RCTs) are investigating the effects
of statins on pre‐eclampsia (PE) and fetal growth restriction (FGR). This cross‐species meta …